CMDh: Update of the Q&A List Variations
Recommendation
28/29 April 2026
From QbD to Process Validation
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
A revision of the "Q&A - List for the submission of variations according to Commission Regulation (EC) 1234/2008" was prepared in May 2020 and published on the HMA (Heads of Medicines Agencies) website. This document lists and answers general questions regarding variation procedures and their submissions for human and veterinary medicinal products.
A new question and its answer have been added in section 1.9 "How do I notify an update of the contact details of the qualified person for pharmacovigilance (QPPV) specified in the application form / Part IA for MRP/DCP or purely nationally authorised products?"
Here, you will find both versions of the Q&A document: with track changes and the final version.
Related GMP News
18.03.2026ICH M4Q(R2): List of comments published
11.03.2026ASMF: CMDh updates Information on "Worksharing Procedure"
04.03.2026CMDh: Update of Q&As for Generic Drug Submissions
18.02.2026HMA/CMDh: Update to the Best Practice Guides on Variations
11.02.2026Q&As for Centralized Procedures - further Update
04.02.2026EMA: IRIS Document revised